Archive for October, 2009
Chest X-Ray Abnormalities Associated with H1N1 Influenza Infection
Patchy consolidation, often bilateral, was the most common finding in chest X-rays of patients with suspected 2009 H1N1 influenza. (more…)
Zanamivir (Relenza) Must Not Be Given by Nebulization
Ventilator obstruction was blamed for the death of a woman who received zanamivir inhalation powder that was solubilized and administered by mechanical ventilation. (more…)
President Obama Declares H1N1 a ‘National Emergency’
President Obama declared over the weekend that the 2009 H1N1 pandemic constitutes a national emergency.
Use of Ribavirin to Treat Influenza
CORRESPONDENCE
Use of Ribavirin to Treat Influenza
K.M. Chan-Tack, J.S. Murray, and D.B. Birnkrant
With the current H1N1 influenza pandemic, questions have arisen regarding the potential for ribavirin as a treatment option. These authors report that the published studies are inconclusive regarding the potential clinical benefits of the drug for the treatment of influenza.
Full Text | PDF | [...]
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
ORIGINAL ARTICLE
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
F.-C. Zhu and Others
The administration of an inactivated vaccine against the 2009 H1N1 virus achieved typical protective immune responses after one dose in subjects between 12 and 60 years of age, whereas two doses were required for younger subjects (3 to 11 years of age).
Full [...]
Seasonal Flu Vaccine Fluarix Approved for Children
The FDA has approved Fluarix, an inactivated seasonal influenza vaccine, for use in children ages 3 to 17 years. The vaccine was previously approved for adults.
2009 H1N1 Influenza in a Tour Group in China
Influenza developed in 30% of tour members who had talked with an H1N1-infected woman in the group but in none who had not. READ MORE …
H1N1 Rapid Tests: Poor Sensitivity
Rapid tests for seasonal influenza generally have relatively low sensitivity; their sensitivity for detecting the 2009 H1N1 virus seems even worse. READ MORE …
CDC Releases 2009 H1N1 Vaccine Schedules
Children aged 6 months through 9 years should receive two doses of 2009 H1N1 vaccine roughly 4 weeks apart, the CDC announced in MMWR.
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand
ORIGINAL ARTICLE
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand
The ANZIC Influenza Investigators
The overall rate of ICU admission for 2009 H1N1 influenza was estimated to be 28.7 per million persons. During the period of peak transmission in communities, the ICU bed-occupancy rate for influenza ranged from 8.9 to 19.0%.
Full Text | PDF [...]
Entries (RSS)